Ticker
SBTX
Analysis
Skinbiotherapeutics Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to SBTX.
Skinbiotherapeutics Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to SBTX.
SBTX
Stock
$37.6M
Health Technology
Pharmaceuticals: Other
GBX
Skinbiotherapeutics Plc may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Trading in Skinbiotherapeutics PLC ordinary shares of 1p each has been restored on AIM effective from 08 June 2026 at 7:30 am, following the publication of its half-yearly repor...
SkinBioTherapeutics plc has completed its board investigation into financial statements, including those for the year ended 30 June 2025, and anticipates publishing its HY26 res...
SkinBioTherapeutics plc has announced that FRP Advisory is nearing the completion of its forensic investigation, with a report expected for the Board in the coming days. Followi...
Mark H Dixon and Diana Dixon, through Rock Nominees Limited, have acquired a major holding in SkinBioTherapeutics plc, now holding 23.537% of the voting rights, representing 61,...
SkinBioTherapeutics plc expects its shares to be suspended from trading on April 1, 2026, due to a delay in publishing its interim results for the six months ended December 31, ...
Review valuation context for Skinbiotherapeutics Plc.
Review future growth context for Skinbiotherapeutics Plc.
Review past performance context for Skinbiotherapeutics Plc.
Review financial health context for Skinbiotherapeutics Plc.
Review dividend context for Skinbiotherapeutics Plc.
Review management context for Skinbiotherapeutics Plc.
Review ownership context for Skinbiotherapeutics Plc.
Review other information context for Skinbiotherapeutics Plc.
Review community context for Skinbiotherapeutics Plc.